Aberdeen Group’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $975K | Buy |
211,059
+20,600
| +11% | +$102K | ﹤0.01% | 834 |
|
|
2026
Q1 | $882K | Sell |
190,459
-273,837
| -59% | -$1.43M | ﹤0.01% | 836 |
|
|
2025
Q4 | $2.32M | Buy |
464,296
+2,145
| +0.5% | +$11.2K | ﹤0.01% | 765 |
|
|
2025
Q3 | $2.29M | Sell |
462,151
-123,177
| -21% | -$543K | ﹤0.01% | 767 |
|
|
2025
Q2 | $2.52M | Sell |
585,328
-8,194
| -1% | -$40.5K | ﹤0.01% | 763 |
|
|
2025
Q1 | $3.58M | Buy |
593,522
+5,521
| +0.9% | +$27.9K | 0.01% | 711 |
|
|
2024
Q4 | $2.19M | Buy |
588,001
+56,392
| +11% | +$253K | ﹤0.01% | 756 |
|
|
2024
Q3 | $3.11M | Buy |
531,609
+11,504
| +2% | +$56.7K | 0.01% | 725 |
|
|
2024
Q2 | $2.24M | Buy |
520,105
+1,887
| +0.4% | +$9.04K | ﹤0.01% | 741 |
|
|
2024
Q1 | $2.44M | Sell |
518,218
-8,920
| -2% | -$34.2K | ﹤0.01% | 754 |
|
|
2023
Q4 | $2.59M | Buy |
527,138
+401,920
| +321% | +$1.97M | 0.01% | 755 |
|
|
2023
Q3 | $682K | Buy |
125,218
+2,622
| +2% | +$21K | ﹤0.01% | 787 |
|
|
2023
Q2 | $1.14M | Sell |
122,596
-11,214
| -8% | -$94.8K | ﹤0.01% | 779 |
|
|
2023
Q1 | $1.1M | Buy |
133,810
+5,987
| +5% | +$66.1K | ﹤0.01% | 787 |
|
|
2022
Q4 | $1.42M | Sell |
127,823
-14,072
| -10% | -$164K | ﹤0.01% | 737 |
|
|
2022
Q3 | $1.68M | Sell |
141,895
-99,778
| -41% | -$1.51M | 0.01% | 732 |
|
|
2022
Q2 | $3.85M | Sell |
241,673
-143,113
| -37% | -$2.57M | 0.01% | 605 |
|
|
2022
Q1 | $8.22M | Buy |
384,786
+448
| +0.1% | +$9.65K | 0.02% | 484 |
|
|
2021
Q4 | $9.08M | Buy |
384,338
+7,744
| +2% | +$166K | 0.02% | 509 |
|
|
2021
Q3 | $7.79M | Buy |
376,594
+1,021
| +0.3% | +$20.9K | 0.02% | 564 |
|
|
2021
Q2 | $7.55M | Buy |
375,573
+54,651
| +17% | +$1.17M | 0.02% | 563 |
|
|
2021
Q1 | $6.83M | Sell |
320,922
-582,132
| -64% | -$12.5M | 0.02% | 574 |
|
|
2020
Q4 | $19.7M | Buy |
903,054
+9,707
| +1% | +$189K | 0.05% | 322 |
|
|
2020
Q3 | $15.8M | Sell |
893,347
-24,647
| -3% | -$459K | 0.04% | 334 |
|
|
2020
Q2 | $17.3M | Buy |
917,994
+8,297
| +0.9% | +$147K | 0.05% | 321 |
|
|
2020
Q1 | $15.7M | Buy |
909,697
+121,986
| +15% | +$2.55M | 0.05% | 313 |
|
|
2019
Q4 | $16.6M | Buy |
787,711
+701,217
| +811% | +$14.2M | 0.04% | 363 |
|
|
2019
Q3 | $1.69M | Buy |
86,494
+4,062
| +5% | +$74.6K | ﹤0.01% | 735 |
|
|
2019
Q2 | $1.44M | Hold |
82,432
| – | – | ﹤0.01% | 785 |
|
|
2019
Q1 | $1.53M | Sell |
82,432
-13,710
| -14% | -$244K | ﹤0.01% | 762 |
|
|
2018
Q4 | $1.55M | Hold |
96,142
| – | – | ﹤0.01% | 721 |
|
|
2018
Q3 | $1.43M | Buy |
+96,142
| New | +$1.4M | ﹤0.01% | 763 |
|
Other funds holding MPT
WAM
Aberdeen Group's MPT Position: Q2 2026 in Review
Aberdeen Group increased its Medical Properties Trust (MPT) stake by 11% in Q2 2026, buying an estimated $102K and bringing the position to 211,059 shares worth $975K. The position accounts for ﹤0.01% of the portfolio, ranked #834.
Aberdeen Group first reported a position in MPT in Q3 2018 and has held it in 32 quarters since. The position peaked at $19.7M in Q4 2020. 490 funds tracked by Wall St. Rank hold MPT as of Q2 2026.
- Aberdeen Group held 211,059 shares of Medical Properties Trust worth $975K as of Q2 2026.
- Aberdeen Group bought 20,600 Medical Properties Trust shares in Q2 2026, an estimated $102K.
- Medical Properties Trust made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #834 holding.
- Aberdeen Group first reported a position in Medical Properties Trust in Q3 2018 and has held it in 32 quarters since.
- Aberdeen Group's Medical Properties Trust position peaked at $19.7M in Q4 2020.
- 490 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.
Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.